Cerebrovascular Accidents and Ranibizumab

Ophthalmology

Volumn 116, Issue 9, 2009, Pages 1834-1835

  Moorthy, Sonia ^a   Cheung, Ning ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RANIBIZUMAB; RHUFAB; UNCLASSIFIED DRUG; VERTEPORFIN;

CEREBROVASCULAR ACCIDENT; FOLLOW UP; HUMAN; LETTER; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK; STATISTICAL ANALYSIS; SUBRETINAL NEOVASCULARIZATION; THROMBOEMBOLISM;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; HUMANS; INCIDENCE; INJECTIONS; MACULAR DEGENERATION; MYOCARDIAL INFARCTION; ODDS RATIO; RISK FACTORS; STROKE; VITREOUS BODY;

EID: 69249169157     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.04.008     Document Type: Letter

References (2)

1. Ueta T., Yanagi Y., Tamaki Y., and Yamaguchi T. Cerebrovascular accidents in ranibizumab. Ophthalmology 116 (2009) 362
2. Gillies M.C., and Wong T.Y. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 356 (2007) 748-749 author reply 749-50